Vadilal Enterp. Q1 FY27 Results (NSE: VADILENT)

· Analysis by Alpha Inflection

Signal: Growth reaccelerated

The read

The quarter delivered revenue growth of +36.2% YoY and a QoQ turnaround from ₹4.22 crore loss to ₹23.30 crore PAT, but the core trajectory weakened: EBITDA growth of +17.3% lagged revenue by 18.9 percentage points and gross margin contracted 260bps to 22.0% as purchases and inventory costs rose to 78.0% of revenue. The key question is whether this margin absorption is transient, since the filing does not disclose its cause.

Vadilal Enterp. Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹703.66 Cr36.2%+141.6%
EBIT₹33.22 Cr15.6%
Net profit₹23.3 Cr15.9%
EPS₹270.0915.9%
EBIT margin5.6%

P&L walk

Standalone revenue increased to ₹703.66 crore, +36.2% YoY and +141.6% QoQ, but gross margin compressed to 22.0% from 24.6% YoY as purchases and inventory costs rose to 78.0% of revenue; EBITDA grew only +17.3% YoY to ₹39.2 crore, while PAT rose +15.9% to ₹23.30 crore.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.